Description
ARA-290 10mg — innate repair receptor agonist for neuroprotection research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from erythropoietin (EPO). It selectively activates the innate repair receptor (IRR) without the erythropoietic effects of EPO, making it a valuable research tool for studying tissue protection mechanisms.
What the Research Shows
Research has examined ARA-290’s effects on neuroprotection, anti-inflammation, and tissue repair through IRR activation. Unlike EPO, it does not stimulate red blood cell production, allowing isolated study of cytoprotective pathways.
Clinical trials have investigated its effects in diabetic neuropathy and sarcoidosis. Published data provides well-characterised pharmacokinetics and safety profiles for research design.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity. No generic overseas certificates.
→ Explore the Peptide Research Library
Purity: ≥99% (HPLC)
Form: Lyophilised powder
Molecular Weight: 1257.5 Da
Length: 11 amino acids
Target: Innate Repair Receptor (IRR)
Research: PubMed
▸ Australian university verified
▸ ≥99% purity guaranteed
▸ Same-day dispatch from Sydney
▸ Research-grade lyophilised powder
Related Research and Resources
For research use only. Not for human consumption.




